,:

Oscar Soto-Angona1,2,3,4, Oscar Andión5, Pablo Sabucedo6

  • 1Department of Psychiatry and Forensic Medicine, Universitat Autonoma de Barcelona, Cerdanyola del Vallés, Spain.

Scientific reports
|September 1, 2025
PubMed
まとめ

アヤワスカアシストされた意味復元療法 (A-MR) は,重度の悲しみの症状を軽減する見込みを示しています. この研究では,A-MRが 単独の治療や治療なしの治療よりも安全で効果的であることが判明しました.

関連する概念動画

Bonanno's Theory of Grieving01:17

Bonanno's Theory of Grieving

Grieving is a complex psychological and emotional process that varies significantly among individuals. George Bonanno's research on bereavement identified four distinct patterns of grieving, offering a nuanced understanding of how people cope with significant loss, such as the death of a spouse, over extended periods. These patterns — resilience, recovery, chronic dysfunction, and delayed grief — highlight the diversity in emotional responses and adaptive mechanisms.
Resilience
155
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
182
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260